🇺🇸 FDA
Patent

US 11174320

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 11174320 (HER3 specific monoclonal antibodies for diagnostic and therapeutic use) held by The Board of Regents of the University of Texas System expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K39/39558, A61K45/06, A61P